A detailed history of Beacon Pointe Advisors, LLC transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 2,428 shares of PPH stock, worth $210,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,428
Previous 2,428 -0.0%
Holding current value
$210,240
Previous $222,000 3.6%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$82.63 - $90.89 $200,625 - $220,680
2,428 New
2,428 $220,000
Q1 2023

May 12, 2023

BUY
$73.68 - $79.63 $23,430 - $25,322
318 Added 10.42%
3,371 $261,000
Q2 2022

Aug 11, 2022

BUY
$72.65 - $83.96 $25,427 - $29,385
350 Added 12.95%
3,053 $235,000
Q1 2022

May 17, 2022

BUY
$73.73 - $80.41 $199,292 - $217,348
2,703 New
2,703 $216,000

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.